Low rate of seroconversion in a retrospective study analyzing QuantiFERON TB-gold testing in psoriasis and hidradenitis suppurativa patients taking biologic therapy at an academic center in New York City

Published: 19 December 2023| Version 1 | DOI: 10.17632/t4mj454jwy.1
Contributors:
Apostolos Katsiaunis, Jade Conway, Debra D'Angelo, Shari Lipner

Description

Low rate of seroconversion in a retrospective study analyzing QuantiFERON TB-gold testing in psoriasis and hidradenitis suppurativa patients taking biologic therapy at an academic center in New York City

Files

Categories

Biologic Therapy, Psoriasis, Hidradenitis Suppurativa

Licence